Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats

Psychopharmacology (Berl). 2014 Jun;231(11):2311-20. doi: 10.1007/s00213-013-3394-0. Epub 2013 Dec 17.

Abstract

Rationale: Chemotherapy, used for the treatment of cancer, often produces cognitive impairment that has been related to suppression of neurogenesis. Physical exercise, which promotes neurogenesis, is known to improve cognitive function in neurologically challenged animals and humans. It is unknown whether exercise similarly protects against chemotherapy-induced cognitive impairment and whether recovery of neurogenesis is a critical factor.

Objective: The present study investigated the relationship between hippocampal neurogenesis and cognitive performance in chemotherapy-treated rats that engaged in different amounts of physical activity.

Methods: Groups of rats, housed individually in standard cages or in specially designed cages that allowed unlimited access to a running wheel, received three injections of the chemotherapeutic drugs methotrexate and 5-fluorouracil, or equal volumes of saline. They were then administered the following cognitive tests in a water maze: (1) spatial memory (SM), (2) cued memory, (3) non-matching to sample (NMTS) rule learning; (4) delayed NMTS (DNMTS). Hippocampal neurogenesis was quantified by counting doublecortin-expressing cells in the dentate gyrus.

Results: Chemotherapy administered to rats in standard cages resulted in a significant reduction in hippocampal neurogenesis and impaired performance on the SM, NMTS, and DNMTS tasks. In rats receiving chemotherapy and housed in exercise cages, neurogenesis was not suppressed and cognitive performance was similar to controls.

Conclusions: Physical exercise can reduce cognitive deficits that result from chemotherapy and this effect is mediated, at least in part, by preventing suppression of drug-induced hippocampal neurogenesis. The results suggest benefits of exercise in preventing or treating cognitive impairment associated with chemotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / adverse effects*
  • Body Weight
  • Cognition Disorders / chemically induced*
  • Cognition Disorders / physiopathology
  • Cognition Disorders / prevention & control*
  • Cues
  • Dentate Gyrus / drug effects*
  • Dentate Gyrus / physiopathology
  • Doublecortin Domain Proteins
  • Doublecortin Protein
  • Female
  • Fluorouracil / adverse effects
  • Housing, Animal
  • Immunohistochemistry
  • Learning / drug effects
  • Learning / physiology
  • Memory / drug effects
  • Memory / physiology
  • Methotrexate / adverse effects
  • Microtubule-Associated Proteins / metabolism
  • Motor Activity / drug effects
  • Motor Activity / physiology*
  • Neurogenesis / drug effects*
  • Neurogenesis / physiology
  • Neuropeptides / metabolism
  • Neuropsychological Tests
  • Rats, Long-Evans
  • Spatial Memory / drug effects
  • Spatial Memory / physiology

Substances

  • Antimetabolites, Antineoplastic
  • Dcx protein, rat
  • Doublecortin Domain Proteins
  • Doublecortin Protein
  • Microtubule-Associated Proteins
  • Neuropeptides
  • Fluorouracil
  • Methotrexate